Evidence map›Paper›PMID 29253688›Full record

ArticleProtein expression and purification2018

Secretion, isotopic labeling and deglycosylation of N-acylethanolamine acid amidase for biophysical studies.

Spiro Pavlopoulos, Dimitrios N Pelekoudas, Othman Benchama, Catherine M Rawlins, Jeffrey N Agar, Jay M West, Michael Malamas, Nikolai Zvonok, Alexandros Makriyannis

Open access · greenAbstract read
In one paragraph

Article in Protein expression and purification, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 2 countries.

Spiro PavlopoulosCenter for Drug Discovery, Department of Pharmaceutical Sciences, Department of Chemistry, Chemical Biology, Northeastern University, Boston, MA, 02115-5000, United States. Electronic address: s.pavlopoulos@northeastern.edu.
Dimitrios N PelekoudasCenter for Drug Discovery, Department of Pharmaceutical Sciences, Department of Chemistry, Chemical Biology, Northeastern University, Boston, MA, 02115-5000, United States.
Othman BenchamaCenter for Drug Discovery, Department of Pharmaceutical Sciences, Department of Chemistry, Chemical Biology, Northeastern University, Boston, MA, 02115-5000, United States.
Catherine M RawlinsBarnett Institute of Chemical and Biological Analysis Northeastern University, Boston, MA, 02115-5000, United States.
Jeffrey N AgarBarnett Institute of Chemical and Biological Analysis Northeastern University, Boston, MA, 02115-5000, United States; Center for Drug Discovery, Department of Pharmaceutical Sciences, Department of Chemistry, Chemical Biology, Northeastern University, Boston, MA, 02115-5000, United States.
Jay M WestCenter for Drug Discovery, Department of Pharmaceutical Sciences, Department of Chemistry, Chemical Biology, Northeastern University, Boston, MA, 02115-5000, United States.
Michael MalamasCenter for Drug Discovery, Department of Pharmaceutical Sciences, Department of Chemistry, Chemical Biology, Northeastern University, Boston, MA, 02115-5000, United States.
Nikolai ZvonokCenter for Drug Discovery, Department of Pharmaceutical Sciences, Department of Chemistry, Chemical Biology, Northeastern University, Boston, MA, 02115-5000, United States.
Alexandros MakriyannisCenter for Drug Discovery, Department of Pharmaceutical Sciences, Department of Chemistry, Chemical Biology, Northeastern University, Boston, MA, 02115-5000, United States; King Abdulaziz University, Jeddah, 22254, Saudi Arabia.
Northeastern University · US

Funding

Novel Probes for N-Acylethanolamine-Hydrolyzing Acid Amidase FunctionR33DA037575 · NIDA · NORTHEASTERN UNIVERSITY · PI PAVLOPOULOS, SPIRO · 2018 to 2019
$785k
Novel Probes for N-acylethanolamine-hydrolyzing acid amidase functionR21DA037575 · NIDA · NORTHEASTERN UNIVERSITY · PI PAVLOPOULOS, SPIRO · 2014 to 2015
$383k
NIDA NIH HHS R21 DA037575NIDA NIH HHS R33 DA037575
6 · The paper itself

Abstract

N-acylethanolamine acid amidase (NAAA) is an N-terminal nucleophile (Ntn) enzyme with a catalytic cysteine residue that has highest activity at acidic pH. The most prominent substrate hydrolyzed is palmitoylethanolamine (PEA), which regulates inflammation. Inhibitors of NAAA have been shown to increase endogenous levels of PEA, and are of interest as potential treatments for inflammatory disorders and other maladies. Currently, there are no X-ray or NMR structures of NAAA available to inform medicinal chemistry. Additionally, there are a limited number of enzyme structures available that are within the Ntn-hydrolase family, have a catalytic cysteine residue, and have a high sequence homology. For these reasons, we developed expression and purification methods for the production of enzyme samples amenable to structural characterization. Mammalian cells are necessary for post-translational processing, including signal sequence cleavage and glycosylation, that are required for a correctly folded zymogen before conversion to active, and mature enzyme. We have identified an expression construct, mammalian cell line, specific media and additives to express and secrete hNAAA zymogen and we further optimized propagation conditions and show this secretion method is suitable for isotopic labeling of the protein. We refined purification methods to achieve a high degree of protein purity potentially suited to crystallography. Glycosylated proteins can present challenges to biophysical methods. Therefore we deglycosylate the enzyme and show that the activity of the mature enzyme is not affected by deglycosylation.

Indexed as

Gene ExpressionAmidohydrolasesCell LineGlycosylationHumansHydrolysisIsotope LabelingAmidohydrolasesNAAA protein, humanCysteine-hydrolaseDeglycosylationIMACIon-exchangeIsotopic-labelingMALDI-TOFNMRPurification

Identifiers

PMID29253688
PMCPMC6022831
OpenAlexW2774583435

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.